SCHEMBL4465211

SCHEMBL4465211

CN1CCN(Cc2ccc(C(N)=O)cn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.48
MAP3K11 Q16584 1/20 0.47
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46
HDAC6 Q9UBN7 2/20 0.46
OPRM1 P35372 2/20 0.46
OPRK1 P41145 2/20 0.46
PAICS P22234 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NNMT P40261 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPK7 Q13164 1/20 0.42
CHEK1 O14757 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4452722 0.89 HRH3 (0.48) HRH3PRMT5WDR77OPRM1OPRK1
SCHEMBL15251306 0.87 HRH3 (0.57) HRH3PRMT5WDR77HDAC6OPRM1
SCHEMBL9202121 0.83 CHKA (0.55) HRH3HDAC6PAICSKDM4EALDH1A1
SCHEMBL15251315 0.83 KDM5C (0.52) HRH3PRMT5WDR77OPRM1OPRK1
SCHEMBL27815604 0.83 HRH3 (0.61) HRH3PRMT5WDR77OPRM1OPRK1
SCHEMBL4465984 0.82 OPRM1 (0.41) HRH3MAP3K11PRMT5WDR77OPRM1
SCHEMBL5133060 0.79 HRH3 (0.48) HRH3MAP3K11HDAC6PAICSKDM4E
SCHEMBL9377535 0.79 HDAC6 (0.51) HRH3HDAC6ALDH1A1SMN1; SMN2MAPK7
SCHEMBL4454098 0.79 NNMT (0.40) HRH3MAP3K11PRMT5WDR77OPRM1
SCHEMBL16621368 0.78 OPRM1 (0.46) HRH3MAP3K11HDAC6OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed